Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

GABA and glutamate balance (inhibitory and excitatory tone)

GABA / Glutamate Balance · Neurotransmission and synaptic plasticity

Allosterically activates the inhibitory GABA-A chloride channel, or physiologically antagonizes NMDA glutamate receptors, quieting excessive firing of cortical neurons and excitotoxicity.

Why it matters: Eases anxiety disorders, excessive brain arousal, bedtime rumination and neuronal injury from excitotoxicity.

Molecular targets: GABA-A receptor chloride channel, NMDA receptor GluN subunit, GAD (glutamate decarboxylase)

Supplements acting on this mechanism (ranked by strength and evidence)

Pyridoxal 5’-phosphate (active vitamin B6)

★★★★☆Mechanism evidence: grade B

PLP is an essential coenzyme for glutamate decarboxylase, which converts glutamate into the inhibitory neurotransmitter GABA. Small human studies provide related biochemical evidence, but this does not guarantee that brain GABA rises in well-nourished people after supplementation.

Ashwagandha

★★★☆☆Mechanism evidence: grade C

The extract shows GABA-related effects in some animal models, but its active constituents and targets in humans are not yet defined. Improved sleep or stress in humans does not prove that GABA-A receptors are occupied, and it cannot be equated with the pharmacology of benzodiazepines.

L-theanine

★★★☆☆Mechanism evidence: grade C

L-theanine is structurally similar to glutamate. In animal studies it altered GABA- and glutamate-related markers in the brain, but the direction of the results differed between models. Human studies have found increased EEG alpha activity and a subjective sense of relaxation. These outcomes alone cannot show whether it acts specifically on GABA-A or NMDA receptors.

Magnesium L-threonate

★★★☆☆Mechanism evidence: grade C

Magnesium ions block NMDA receptor channels in a voltage-dependent way, and this physiological effect is established. Whether this oral product strengthens that block in the human brain, and so prevents excitotoxicity, is not directly supported by evidence. Animal mechanisms also cannot be directly extrapolated to usual human doses.

Apigenin

★★★☆☆Mechanism evidence: grade C

Animal studies suggest apigenin’s sedative effect may involve GABAergic pathways. However, a benzodiazepine-site antagonist blocked only part of the sedative effects and receptor-level results are inconsistent, so its specificity for that site cannot yet be determined. A sedative effect in humans has not been established, and this cannot be taken to mean that ataxia will not occur.

Dihydromyricetin (DHM, vine tea extract)

★★★☆☆Mechanism evidence: grade C

Rat and isolated-receptor experiments show that dihydromyricetin can reduce some ethanol effects linked to GABA-A receptors. Most of these studies gave it by injection, so they do not show that usual oral doses reach effective concentrations in the human brain.

Creatine monohydrate

★★☆☆☆Mechanism evidence: grade B

Animal and in-vitro studies suggest that creatine may reduce glutamate-related excitotoxic injury through energy buffering. In one small human study without a placebo control, brain MR spectroscopy showed a drop in the glutamate-related signal, but this is a total tissue signal and says nothing specific about extrasynaptic glutamate. The proposed mechanism of blocked transporter reversal has not been confirmed.

Myo-inositol and D-chiro-inositol 40:1 complex

★★☆☆☆Mechanism evidence: grade C

In a mouse experiment, adding inositol to drinking water raised hippocampal GABA and expression of some GABA receptor subunits. This does not show that inositol directly activates GABA-A receptors. 5-HT2 is a serotonin receptor, so effects on it are not evidence of GABAergic activation, and receptor effects and clinical benefit in humans have not been confirmed.

Magnesium bisglycinate

★★☆☆☆Mechanism evidence: grade D

Magnesium blocks NMDA channels in a voltage-dependent way, and this cellular effect is well established. However, there is no human evidence on whether oral magnesium bisglycinate raises free magnesium in the brain and strengthens that block. Glycine does not directly activate GABA receptors. It is also a co-agonist at NMDA receptors.

Agmatine sulfate

★★☆☆☆Mechanism evidence: grade D

In-vitro binding experiments suggest agmatine acts on polyamine-related sites of the NMDA receptor, opposing spermine-like enhancement. Blocking the channel directly requires higher concentrations, and there are no measurements of NMDA receptor occupancy in the human brain at usual oral doses.

Huperzine A

★☆☆☆☆Mechanism evidence: grade D

In vitro, huperzine A can block the NMDA channel, with an apparent Ki of about 6 μM. After a single 400 μg oral dose in humans, peak plasma concentration was only about 2.59 ng/mL, or about 11 nM. Brain concentration has not been measured directly, and an NMDA-blocking effect at usual doses has not been confirmed.

Polygala tenuifolia extract

★☆☆☆☆Mechanism evidence: grade D

In cultured neurons, Polygala can reduce NMDA-induced damage, but this does not mean it directly blocks the NMDA ion channel. There is currently no reliable evidence for direct receptor antagonism or for a neuroprotective effect in humans.

Open in the interactive app ›